Skip to Main Content

Mary E. (Beth) McCarville, MD

Emeritus, St. Jude Faculty

On this page:

Contact Information

Mary E. (Beth) McCarville, MD

Department of Radiology

MS 220, Room I3117

St. Jude Children's Research Hospital

262 Danny Thomas Place

MemphisTN 38105-3678

Education

RT – Iowa Methodist Medical Center, School of Radiologic Technology, Des Moines, IA (1977) BS – University of Iowa, Iowa City, IA (1986) MD – University of Iowa College of Medicine, Iowa City, IA (1990)

Honors & Awards

  • 2009-2017  Recognized in Best Doctors in America®
  • 2015  John Caffey Award for Best Clinical Science Paper presented at the 2015 annual meeting of the Society for Pediatric Radiology: Contrast Enhanced Ultrasound in the Assessment of Pediatric Solid Tumor Response to Anti-Angiogenic Therapy.  McCarville MB, Coleman J, Guo J, Li Y, Li X, Navid F. 
  • 2011  Certificate of Merit from the Society for Pediatric Radiology presented at the International Paediatric Radiology Congress, May 27th-31st, 2011, London, UK, for the scientific exhibit: Ultrasound and Magnetic Resonance Imaging Features of Unusual Ocular Disease in Children with Clinical and Pathological Correlation. McCarville MB, Kaste SC, Wilson W.
  • 2005  John Caffey Award for Basic Science Research from the Society for Pediatric Radiology, presented at the 2005 annual meeting, for the oral presentation: Quantitative Measurement of Microbubble Ultrasound Contrast Agent Flow To Assess the Efficacy of Angiogenesis Inhibitors In Vivo. McCarville B, Streck C, Li C-S, Davidoff A.
  • 2004  Certificate of Merit from the Society for Pediatric Radiology presented at the 2004 annual meeting, for the scientific exhibit: Not all 18FDG-Avid Sites Represent Active Disease in Pediatric Hodgkin’s. Kaste SC, Howard S, McCarville MB, Krasin MJ, Hudson MM.

Research Interests

  • Ultrasound

Clinical Trials

Closed
DWSARC: Diffusion Weighted Magnetic Resonance Imaging In Pediatric Sarcomas

Study goal:

To estimate the ability of the whole body diffusion weighted MRI (WB DWI) to correctly identify pediatric sarcoma patients with and without bone/bone marrow and soft-tissue metastases at the time of diagnosis. 

To determine the correlation between changes in primary pediatric sarcoma 18-F fluorodeoxyglucose positron emission tomography (FDG PET) maximum standardized uptake values (SUVmax) and average DWI apparent diffusion coefficient (ADC) values from baseline (pre-treatment) to just prior to local control.